These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7767151)

  • 21. Effect of acyclovir on radiation- and chemotherapy-induced mouth lesions.
    Bubley GJ; Chapman B; Chapman SK; Crumpacker CS; Schnipper LE
    Antimicrob Agents Chemother; 1989 Jun; 33(6):862-5. PubMed ID: 2669626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies.
    Baker D; Eisen D
    Cutis; 2003 Mar; 71(3):239-42. PubMed ID: 12661753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
    Tyring SK; Douglas JM; Corey L; Spruance SL; Esmann J
    Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials.
    Spruance SL; Nett R; Marbury T; Wolff R; Johnson J; Spaulding T
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2238-43. PubMed ID: 12069980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylaxis against herpes labialis with acyclovir cream--a placebo-controlled study.
    Gibson JR; Klaber MR; Harvey SG; Tosti A; Jones D; Yeo JM
    Dermatologica; 1986; 172(2):104-7. PubMed ID: 3512326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis.
    Spruance SL
    J Med Virol; 1993; Suppl 1():27-32. PubMed ID: 8245889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Oral acyclovir therapy in recurrent herpes simplex].
    Djawari D
    Z Hautkr; 1986 Nov; 61(22):1629-32, 1637. PubMed ID: 3811459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infections.
    Van Vloten WA; Swart RN; Pot F
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():89-93. PubMed ID: 6355055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies in the prophylaxis of herpes infections in severely immunocompromised patients using acyclovir.
    Prentice HG; Hann IM
    Schweiz Med Wochenschr Suppl; 1983; 14():26-9. PubMed ID: 6361988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral acyclovir in the suppression of recurrent non-genital herpes simplex virus infection.
    Meyrick Thomas RH; Dodd HJ; Yeo JM; Kirby JD
    Br J Dermatol; 1985 Dec; 113(6):731-5. PubMed ID: 3913459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acyclovir in the prevention of duodenal ulcer recurrence.
    Rune SJ; Linde J; Bonnevie O; Petersen HD; Bendtsen F; Wandall JH; Gluud C; Eriksen J; Skovbjerg H; Vilien M
    Gut; 1990 Feb; 31(2):151-2. PubMed ID: 2179067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpes simplex and cytomegalovirus coinfected oral ulcers in HIV-positive patients.
    Regezi JA; Eversole LR; Barker BF; Rick GM; Silverman S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Jan; 81(1):55-62. PubMed ID: 8850485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation.
    Wade JC; Newton B; Flournoy N; Meyers JD
    Ann Intern Med; 1984 Jun; 100(6):823-8. PubMed ID: 6326632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral acyclovir (Zovirax) in the treatment of recurrent herpetic gingivostomatitis and recurrent herpes labialis.
    Quong TL
    Hawaii Dent J; 1989 Oct; 20(10):10, 12, 14 passim. PubMed ID: 2630545
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of herpes labialis by photodynamic therapy: Study protocol clinical trial (SPIRIT compliant).
    La Selva A; Negreiros RM; Bezerra DT; Rosa EP; Pavesi VCS; Navarro RS; Bello-Silva MS; Ramalho KM; Aranha ACC; Braz-Silva PH; Fernandes KPS; Bussadori SK; Horliana ACRT
    Medicine (Baltimore); 2020 Mar; 99(12):e19500. PubMed ID: 32195950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A risk-benefit evaluation of aciclovir for the treatment and prophylaxis of herpes simplex virus infections.
    Leflore S; Anderson PL; Fletcher CV
    Drug Saf; 2000 Aug; 23(2):131-42. PubMed ID: 10945375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A long-term prospective clinical study of orofacial herpes simplex virus infection in acute leukemia.
    Barrett AP
    Oral Surg Oral Med Oral Pathol; 1986 Feb; 61(2):149-52. PubMed ID: 3515270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nongenital herpes simplex virus.
    Usatine RP; Tinitigan R
    Am Fam Physician; 2010 Nov; 82(9):1075-82. PubMed ID: 21121552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of recurrent herpes labialis using a herpes simplex Type-I subunit vaccine. A prospective randomized double-blind multicenter study].
    Altmeyer P; Wehrenberg O; Holzmann H; Paul E; Kimmig WK; Wassilew SW; Petres J; Korger G
    Hautarzt; 1991 Dec; 42(12):759-63. PubMed ID: 1662671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral acyclovir for treatment of first-episode herpes simplex virus proctitis.
    Rompalo AM; Mertz GJ; Davis LG; Benedetti J; Critchlow C; Stamm WE; Corey L
    JAMA; 1988 May; 259(19):2879-81. PubMed ID: 3367455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.